SCHEMBL2295166

SCHEMBL2295166

C[C@@](CC(=O)O)(c1ccccc1)n1cnc2cc(N)ccc21

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.46
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
MAPT P10636 4/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
HPGD P15428 3/20 0.40
ALDH1A1 P00352 3/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.38
ACSS2 Q9NR19 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LCK P06239 1/20 0.38
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2292928 0.81 PKM (0.53) FGFR1NPC1RAB9AMAPTHPGD
SCHEMBL2298645 0.81 NPC1 (0.56) NPC1RAB9AMAPTHPGDLMNA
SCHEMBL9231437 0.77 FGFR1 (0.56) FGFR1NPC1RAB9AMAPTHSD17B10
SCHEMBL19848676 0.74 MAPT (0.51) FGFR1NPC1RAB9AMAPTHSD17B10
SCHEMBL29613720 0.74 MAPT (0.51) FGFR1NPC1RAB9AMAPTHSD17B10
SCHEMBL2298534 0.73 EGLN3 (0.45) NPC1RAB9AMAPTHSD17B10CYP2C19
SCHEMBL19911416 0.68 MAPT (0.49) FGFR1MAPTHSD17B10HPGDALDH1A1
SCHEMBL482648 0.68 NR1H2 (0.43) FGFR1MAPTHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL2296957 0.67 HCAR3 (0.50) FGFR1NPC1RAB9AMAPTHSD17B10
SCHEMBL2295849 0.67 FGFR1 (0.47) FGFR1NPC1RAB9AMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003806-B2 Integrin antagonists useful as anticancer agents OSI Pharmaceuticals, LLC (US) 2011-08-23 US disclosed